The combination of a MEK inhibitor plus the SHP-2 inhibitor SHP099 was recently shown to be effective in models of NF1-MPNST and plexiform neurofibroma [44]. The gene discussed is MAP2K7; the disease is malignant peripheral nerve sheath tumor.